| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 06/05/2013 | CN102399286B Protein for promoting bone cell growth and expression vector thereof |
| 06/05/2013 | CN102296101B Method for preparing micro capsulate embedded antihypertensive peptide |
| 06/05/2013 | CN102286408B Bacillus amyloliquefaciens WH3, and preparation method and application thereof |
| 06/05/2013 | CN102212597B Method for producing collagen polypeptide, natural pigment and fish oil by using fish skin and fish scale |
| 06/05/2013 | CN102191194B Bacillus subtilis and antibacterial protein thereof |
| 06/05/2013 | CN102121039B Preparation method of plant immune protein |
| 06/05/2013 | CN101993496B Dual blood sugar and blood fat adjusting fusion protein and preparation method and application thereof |
| 06/05/2013 | CN101899419B Insect baculovirus expression system and method for expressing E2 protein using same |
| 06/05/2013 | CN101809162B Anti-glypican-3 antibody having improved kinetics in plasma |
| 06/05/2013 | CN101712955B Process for producing physiologically active protein using genetically modified silkworm |
| 06/05/2013 | CN101654672B RNA interference mediating small RNA molecules |
| 06/05/2013 | CN101607991B Method for preparing venom edema factor inhibition protein and application thereof |
| 06/05/2013 | CN101501209B A method of producing biologically active polypeptide having insulinotropic activity |
| 06/05/2013 | CN101056979B Anti-histone H1 monoclonal antibody and hybridoma capable of producing the same |
| 06/04/2013 | USRE44266 Expression of eukaryotic polypeptides in chloroplasts |
| 06/04/2013 | US8455629 Human anti-OPGL neutralizing antibodies as selective OPGL pathway inhibitors |
| 06/04/2013 | US8455628 PP1 ligands |
| 06/04/2013 | US8455626 Aβ conformer selective anti-aβ globulomer monoclonal antibodies |
| 06/04/2013 | US8455622 Variant target binding agents and uses thereof |
| 06/04/2013 | US8455453 Use of VEGF-D gene to prevent restenosis |
| 06/04/2013 | US8455445 Methods for inhibiting lymphotoxin-β receptor signaling in TH1 cell-associated disorders |
| 06/04/2013 | US8455438 Natriuretic polypeptides for reducing or preventing restenosis |
| 06/04/2013 | US8455246 Serum-free mammalian cell culture medium, and uses thereof |
| 06/04/2013 | US8455233 improved ability to enzymatically degrade lignocellulosic feedstocks; fermentation |
| 06/04/2013 | US8455223 Dehydrogenases, the derivatives thereof, and method for the production of optically active alkanols |
| 06/04/2013 | US8455220 Biomarkers for assessing liver function |
| 06/04/2013 | US8455218 Methods for G-CSF production in a Pseudomonas host cell |
| 06/04/2013 | US8455217 Nucleic acids encoding IL-17 homologous receptor-like polypeptides and therapeutic uses thereof |
| 06/04/2013 | US8455215 Liquid tissue preparation from histopathologically processed biological samples, tissues and cells |
| 06/04/2013 | US8454976 Recombinant toxin fragments |
| 06/04/2013 | US8454953 Methods for reducing allergies caused by environmental allergens |
| 06/04/2013 | CA2554054C Mixtures of binding proteins |
| 06/04/2013 | CA2499926C Antibody against von willebrand factor cleaving enzyme and assay system using the same |
| 06/04/2013 | CA2448501C Flax (linum usitatissimum l.) seed-specific promoters |
| 05/30/2013 | WO2013078223A1 Anti-factor h binding protein antibodies and methods of use thereof |
| 05/30/2013 | WO2013077645A1 Adenovirus producing novel cell line and the use thereof |
| 05/30/2013 | WO2013077563A1 Halocynthia roretzi-derived sialic acid transferase and method for synthesizing sialicated glycoconjugates using same |
| 05/30/2013 | WO2013077458A1 Anti-human trop-2 antibody exhibiting antitumor activity in vivo |
| 05/30/2013 | WO2013077332A1 Method for detecting matrix metalloproteinase-3 by latex agglutination method |
| 05/30/2013 | WO2012036810A8 Thermophilic mutants of trichoderma reesei endoglucanase i |
| 05/30/2013 | US20130137858 Immobilized proteins and methods and uses thereof |
| 05/30/2013 | US20130137857 Transglycosylation activity of glycosynthase mutants of an endo-beta-n-acetylglucosaminidase (endo-d) from streptococcus pneumoniae |
| 05/30/2013 | US20130137758 Akt activity specifically inhibiting polypeptide |
| 05/30/2013 | US20130137140 Increased protein expression through increased membrane formation |
| 05/30/2013 | US20130137118 Integrin heterodimer and a subunit thereof |
| 05/30/2013 | US20130136760 Streptococcus pyogenes antigens and corresponding dna fragments |
| 05/30/2013 | US20130136747 Anti-amyloid beta antibodies and their use |
| 05/30/2013 | CA2855699A1 Anti-human trop-2 antibody having an antitumor activity in vivo |
| 05/29/2013 | EP2596114A2 Domain insertion immunoglobulin |
| 05/29/2013 | EP2596106A2 Plant-based production of heterologous proteins |
| 05/29/2013 | EP2596017A1 Cross-protective pathogen protection, methods and compositions thereof |
| 05/29/2013 | EP2596010A2 Signal biomarkers |
| 05/29/2013 | EP2595657A2 Anti-tumor antigen antibodies and methods of use |
| 05/29/2013 | CN1911965B Binding domain-immunoglobulin fusion proteins |
| 05/29/2013 | CN1661014B Novel method to isolate mutants and to clone the complementing gene |
| 05/29/2013 | CN1582165B Antibodies to CD40 |
| 05/29/2013 | CN103122363A Preparation method of donkey-hide gelatin oligopeptide |
| 05/29/2013 | CN103122322A Pichia-pastoris engineering bacterium for producing glutathione |
| 05/29/2013 | CN103122027A Recombinant human collagen and production method thereof |
| 05/29/2013 | CN103122022A Angiotensin converting enzyme inhibitory peptide derived from bitter almond protein and preparation method thereof |
| 05/29/2013 | CN102260325B Antibacterial peptide NX-16, and preparation method and application thereof |
| 05/29/2013 | CN101838467B Novel chitosan nanoparticles and preparation method thereof |
| 05/29/2013 | CN101646767B Amylases and glucoamylases, nucleic acids encoding them and methods for making and using them |
| 05/28/2013 | US8450470 Use to faciliate drug delivery of other drugs, or treat glycosaminoglycan associated pathologies, such as scarring, spinal cord injury, glaucoma, and cosmetic treatments |
| 05/28/2013 | US8450460 Single-chain TNFSF fusion polypeptides |
| 05/28/2013 | US8450096 Polypeptides having phytase activity and polynucleotides encoding same |
| 05/28/2013 | US8450087 Use of triplex structure DNA in transferring nucleotide sequences |
| 05/28/2013 | US8450086 Bacterial membrane protein secretion |
| 05/28/2013 | US8450085 Labeled biomolecular compositions and methods for the production and uses thereof |
| 05/28/2013 | US8450084 Chemo-enzymatic peptide synthesis via C-terminal ester interconversion |
| 05/28/2013 | US8449885 Anti-VEGF antibodies |
| 05/28/2013 | US8449884 Clotting factor-fc chimeric proteins to treat hemophilia |
| 05/28/2013 | US8449876 Human lysosomal proteins from plant cell culture |
| 05/28/2013 | CA2693274C Peptide acceptor ligation methods |
| 05/28/2013 | CA2671797C Microbial process for production of enzymes |
| 05/28/2013 | CA2554784C Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
| 05/28/2013 | CA2489595C Recombination of nucleic acid library members |
| 05/28/2013 | CA2476773C Monoclonal antibodies against extracellular loops of c5ar |
| 05/28/2013 | CA2472886C Transgenic plants expressing civps or intein modified proteins and related method |
| 05/28/2013 | CA2443372C Immunotherapeutic combinations for the treatment of tumors that over-express gangliosides |
| 05/28/2013 | CA2440831C Combination therapy using cd40 and cd20 ligands |
| 05/28/2013 | CA2434802C Isolating cells expressing secreted proteins |
| 05/28/2013 | CA2412239C Cytokine receptor zcytor17 |
| 05/28/2013 | CA2324513C Chimeric protein containing an intramolecular chaperone-like sequence and its application to insulin production |
| 05/28/2013 | CA2240292C Recombinant fusion proteins to growth hormone and serum albumin |
| 05/23/2013 | WO2013074598A1 Fc CONTAINING POLYPEPTIDES HAVING INCREASED ANTI-INFLAMMATORY PROPERTIES AND INCREASED FcRN BINDING |
| 05/23/2013 | WO2013074492A1 Methods of treating cancer |
| 05/23/2013 | WO2013073760A1 Novel gene derived from mud flat metagenome and novel protein obtained therefrom showing coactivity of phospholipase and lipase |
| 05/23/2013 | WO2013073219A1 Method for producing insoluble aggregate of neurodegenerative-disease-related protein |
| 05/23/2013 | WO2013071723A1 Preparation method of antibacterial lipopeptide and application thereof to veterinary medicine |
| 05/23/2013 | WO2013042960A3 Method for preparing microvesicular adam15 |
| 05/23/2013 | US20130131317 Expression of secreted human alpha-fetoprotein in transgenic animals |
| 05/23/2013 | US20130131315 Auto-processing domains for polypeptide expression |
| 05/23/2013 | US20130130388 Methods of Modifying Eurakyotic Cells |
| 05/23/2013 | US20130130313 METHOD OF SYNTHESIZING A SUPPRESSOR tRNA, DNA CONSTRUCT AND USE THEREOF FOR PRODUCING A NON-NATURAL AMINO ACID-INCORPORATED PROTEIN |
| 05/23/2013 | US20130130233 Monoclonal antibodies to human immunodeficiency virus and uses thereof |
| 05/23/2013 | US20130129717 Monoclonal Antibodies Against Extracellular Loops of C5aR |
| 05/22/2013 | EP2594589A1 ANTI-Trop-2 ANTIBODY |
| 05/22/2013 | EP2593558A1 Enzyme for the production of optically pure 3 - quinuclidinol |
| 05/22/2013 | CN1961743B 5'-ribonucleotide-rich yeast extract and its production |